5 Best Biotech Penny Stocks to Buy Now

2. Nuvation Bio Inc. (NYSE:NUVB)

Number of Hedge Fund Holders: 29

Nuvation Bio Inc. (NYSE:NUVB) is a clinical stage biotech company that is working on treatments for oncology. In May Nuvation Bio Inc. (NYSE:NUVB) posted Q1 results. GAAP EPS in the first quarter came in at -$0.10.

As of the end of March Nuvation Bio Inc. (NYSE:NUVB) had cash, cash equivalents, and marketable securities of $646.6 million. As of the end of the first quarter of 2023, 29 hedge funds tracked by Insider Monkey were long Nuvation Bio Inc. (NYSE:NUVB).